SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $63,000 | -80.3% | 13,500 | -67.7% | 0.00% | -77.8% |
| Q3 2021 | $319,000 | +25.1% | 41,840 | +58.9% | 0.01% | +12.5% |
| Q2 2021 | $255,000 | +100.8% | 26,330 | +71.2% | 0.01% | +100.0% |
| Q1 2021 | $127,000 | +62.8% | 15,380 | +34.3% | 0.00% | +33.3% |
| Q4 2020 | $78,000 | -64.4% | 11,450 | -41.6% | 0.00% | -66.7% |
| Q3 2020 | $219,000 | +97.3% | 19,610 | -52.7% | 0.01% | +50.0% |
| Q2 2019 | $111,000 | -42.2% | 41,500 | +2.5% | 0.01% | -45.5% |
| Q1 2019 | $192,000 | +291.8% | 40,500 | +100.0% | 0.01% | +175.0% |
| Q4 2018 | $49,000 | -42.4% | 20,250 | +5.2% | 0.00% | -20.0% |
| Q3 2018 | $85,000 | -38.8% | 19,250 | 0.0% | 0.01% | -44.4% |
| Q2 2018 | $139,000 | +85.3% | 19,250 | +32.8% | 0.01% | +80.0% |
| Q1 2018 | $75,000 | – | 14,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |